Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.

Frischknecht, Lukas

Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. [electronic resource] - The Journal of thoracic and cardiovascular surgery Jun 2015 - 1539-46.e1 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-685X

10.1016/j.jtcvs.2015.01.065 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--analysis
Chemotherapy, Adjuvant
DNA-Binding Proteins--analysis
Deoxycytidine--administration & dosage
Disease Progression
Disease-Free Survival
Endonucleases--analysis
Female
Glutamates--administration & dosage
Guanine--administration & dosage
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Lung Neoplasms--enzymology
Male
Mesothelioma--enzymology
Mesothelioma, Malignant
Middle Aged
Multivariate Analysis
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasm Staging
Pemetrexed
Platinum Compounds--administration & dosage
Pleural Neoplasms--enzymology
Pneumonectomy
Predictive Value of Tests
Proportional Hazards Models
Ribonucleoside Diphosphate Reductase
Risk Factors
Time Factors
Tissue Array Analysis
Treatment Outcome
Tumor Suppressor Proteins--analysis
Gemcitabine